by mm-red | Jun 9, 2020
Background: Icatibant is a bradykinin B2-receptor antagonist used for the treatment of hereditary angioedema attacks resulting from C1-inhibitor de ciency. Treatment is not adjusted by body weight however the impact of body mass index (BMI) on the e ectiveness of...
Recent Comments